About treace medical concepts inc - TMCI
Treace Medical Concepts, Inc. engages in the designing, manufacturing, and marketing of orthopedic medical devices and biologic solutions. The firm offers Lapiplasty, a bunion surgery for three-dimensional bunion correction. It operates and distributes its products and services under the following trademarks: Treace Medical Concepts, Lapiplasty, Fast Grafter, Align My Toe, The Future of Hallux Valgus, Fix It Right The First Time, and Plantar Python. The company was founded by John T. Treace in July 2013 and is headquartered in Ponte Vedra Beach, FL.
TMCI At a Glance
Treace Medical Concepts, Inc.
100 Palmetto Park Place
Ponte Vedra Beach, Florida 32081
| Phone | 1-904-373-5940 | Revenue | 212.69M | |
| Industry | Medical Specialties | Net Income | -59,002,000.00 | |
| Sector | Health Technology | 2025 Sales Growth | 1.592% | |
| Fiscal Year-end | 12 / 2026 | Employees | 450 | |
| View SEC Filings |
TMCI Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 0.729 |
| Price to Book Ratio | 1.792 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -4.101 |
| Enterprise Value to Sales | 0.839 |
| Total Debt to Enterprise Value | 0.403 |
TMCI Efficiency
| Revenue/Employee | 472,644.444 |
| Income Per Employee | -131,115.556 |
| Receivables Turnover | 5.01 |
| Total Asset Turnover | 1.043 |
TMCI Liquidity
| Current Ratio | 4.311 |
| Quick Ratio | 3.134 |
| Cash Ratio | 1.579 |
TMCI Profitability
| Gross Margin | 79.812 |
| Operating Margin | -25.461 |
| Pretax Margin | -27.741 |
| Net Margin | -27.741 |
| Return on Assets | -28.946 |
| Return on Equity | -58.936 |
| Return on Total Capital | -37.063 |
| Return on Invested Capital | -34.806 |
TMCI Capital Structure
| Total Debt to Total Equity | 82.286 |
| Total Debt to Total Capital | 45.141 |
| Total Debt to Total Assets | 37.707 |
| Long-Term Debt to Equity | 79.656 |
| Long-Term Debt to Total Capital | 43.698 |